Clinical Trial

Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis:

Study acronym: BEE-SONIC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This double-blind, randomized controlled trial (BEE-SONIC) aims to evaluate the efficacy of bee venom phonophoresis in the treatment of chronic sinusitis. Thirty adult patients (aged 18-65 years) with clinically diagnosed chronic or acute sinusitis will be randomized into two groups: the intervention group will receive bee venom phonophoresis using low-to-moderate intensity ultrasound, while the control group will receive standard care consisting of oral decongestants and saline nasal irrigation. Primary outcomes include improvement in symptom severity (SNOT-22, Visual Analog Scale) and quality of life (SF-33). Secondary outcomes include reduction in facial pain, nasal congestion, and patient satisfaction. Data will be collected at baseline, midpoint, and post-intervention, and analyzed using paired t-tests and ANOVA. The study has received ethics approval from Sinai University's Human Research Ethics Committee, and informed consent will be obtained from all participants.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-10-25 -> 2027-10-25 2026-08-05
minor Completion pushed: 2026-12-25 -> 2027-12-25 2026-08-05
Trial Details
NCT Number NCT07151313
Lead Sponsor Sinai University
Conditions Chronic Sinusitis, Acute Sinusitis, Rhinosinusitis
Enrollment 30 participants
Start Date 2026-08-15
Primary Completion 2027-10-25 (estimated)
Study Completion 2027-12-25 (estimated)
Updated on ClinicalTrials.gov 2026-08-04